GUERBET (GBT.PA) Stock Fundamental Analysis

EPA:GBT • FR0000032526

13.93 EUR
-0.09 (-0.64%)
Last: Feb 13, 2026, 02:52 PM
Fundamental Rating

3

Overall GBT gets a fundamental rating of 3 out of 10. We evaluated GBT against 63 industry peers in the Health Care Equipment & Supplies industry. GBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GBT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • GBT had positive earnings in the past year.
  • In the past year GBT had a positive cash flow from operations.
  • Of the past 5 years GBT 4 years were profitable.
  • GBT had a positive operating cash flow in each of the past 5 years.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.76%, GBT is doing worse than 60.32% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 2.06%, GBT is doing worse than 60.32% of the companies in the same industry.
  • GBT has a worse Return On Invested Capital (3.15%) than 65.08% of its industry peers.
  • GBT had an Average Return On Invested Capital over the past 3 years of 4.08%. This is significantly below the industry average of 9.98%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.15%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.96%, GBT is doing worse than 60.32% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GBT has declined.
  • GBT has a worse Operating Margin (4.19%) than 65.08% of its industry peers.
  • GBT's Operating Margin has declined in the last couple of years.
  • The Gross Margin of GBT (78.03%) is better than 90.48% of its industry peers.
  • In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
  • GBT has about the same amout of shares outstanding than it did 1 year ago.
  • GBT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for GBT is higher compared to a year ago.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 2.06 indicates that GBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of GBT (2.06) is comparable to the rest of the industry.
  • The Debt to FCF ratio of GBT is 8.94, which is on the high side as it means it would take GBT, 8.94 years of fcf income to pay off all of its debts.
  • GBT has a Debt to FCF ratio (8.94) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
  • GBT has a worse Debt to Equity ratio (0.93) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Altman-Z 2.06
ROIC/WACC0.46
WACC6.9%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
  • GBT's Current ratio of 2.32 is fine compared to the rest of the industry. GBT outperforms 68.25% of its industry peers.
  • GBT has a Quick Ratio of 1.03. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of GBT (1.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • The earnings per share for GBT have decreased strongly by -77.27% in the last year.
  • GBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.50% yearly.
  • The Revenue has decreased by -2.01% in the past year.
  • The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

  • GBT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.56% yearly.
  • Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y-96.34%
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.22, GBT is valued on the expensive side.
  • Based on the Price/Earnings ratio, GBT is valued a bit cheaper than 69.84% of the companies in the same industry.
  • GBT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 98.51, GBT can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, GBT is valued a bit more expensive than the industry average as 73.02% of the companies are valued more cheaply.
  • GBT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.69.
Industry RankSector Rank
PE 23.22
Fwd PE 98.51
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • GBT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GBT is cheaper than 95.24% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.95
EV/EBITDA 3.91
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • GBT's earnings are expected to decrease with -10.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
  • GBT's Dividend Yield is rather good when compared to the industry average which is at 0.97. GBT pays more dividend than 85.71% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, GBT pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

  • The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

  • GBT pays out 81.59% of its income as dividend. This is not a sustainable payout ratio.
  • GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.59%
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (2/13/2026, 2:52:00 PM)

13.93

-0.09 (-0.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners10.22%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap176.08M
Revenue(TTM)809.67M
Net Income(TTM)7.73M
Analysts44
Price Target13.26 (-4.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.59%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.75%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-87.44%
EPS NY rev (3m)-87.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 23.22
Fwd PE 98.51
P/S 0.22
P/FCF 3.95
P/OCF 1.88
P/B 0.47
P/tB 0.64
EV/EBITDA 3.91
EPS(TTM)0.6
EY4.31%
EPS(NY)0.14
Fwd EY1.02%
FCF(TTM)3.53
FCFY25.32%
OCF(TTM)7.4
OCFY53.13%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.04
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.45%
ROIC 3.15%
ROICexc 3.64%
ROICexgc 4.3%
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.51%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Debt/EBITDA 3.27
Cap/Depr 66.71%
Cap/Sales 6.05%
Interest Coverage 1.56
Cash Conversion 87.13%
Profit Quality 576.4%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.06
F-Score5
WACC6.9%
ROIC/WACC0.46
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-96.34%
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
EBIT growth 1Y-42.07%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year50.63%
EBIT Next 3Y21.02%
EBIT Next 5Y21.78%
FCF growth 1Y182.18%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2940.2%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the fundamental rating for GBT stock?

ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA.


What is the valuation status of GUERBET (GBT.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to GUERBET (GBT.PA). This can be considered as Overvalued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


What is the financial health of GUERBET (GBT.PA) stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


Is the dividend of GUERBET sustainable?

The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.59%.